Skip to main content
Top
Published in: Respiratory Research 1/2014

Open Access 01-12-2014 | Research

Comparison of inflammatory markers in induced and spontaneous sputum in a cohort of COPD patients

Authors: Solveig Tangedal, Marianne Aanerud, Louise JP Persson, Karl A Brokstad, Per S Bakke, Tomas M Eagan

Published in: Respiratory Research | Issue 1/2014

Login to get access

Abstract

Background

Sputum induction is a non-invasive method for obtaining measurements of inflammation in the airways. Whether spontaneously sampled sputum can be a valid surrogate is unknown. The aim of this study was to compare levels of six inflammatory markers in sputum pairs consisting of induced and spontaneous sputum sampled on the same consultation either in a stable state or during exacerbations of chronic obstructive pulmonary disease (COPD).

Methods

433 COPD patients aged 40-76, Global initiative for chronic Obstructive Lung Disease (GOLD) stage II-IV were enrolled in 2006/07 and followed every six months for three years. 356 patients were followed for potential exacerbations. Interleukin-6, interleukin-8, interleukin-18, interferon gamma-inducible protein-10, monokine induced by gamma interferon and tumor necrosis factor-alpha (IL-6, IL-8, IL-18, IP-10, MIG and TNF-α) were measured by bead based multiplex immunoassay in 60 paired sputum samples from 45 patients. Albumin was measured by enzyme immunoassay, for concentration correction. Culturing for bacterial growth was performed on 24 samples. Bland-Altman plots were used to assess agreement. The paired non-parametric Wilcoxon signed-rank test, the non-parametric Spearman’s rank correlation test and Kruskal-Wallis test were used for statistical analyses. For all analyses, a p-value < 0.05 was considered significant.

Results

Agreement between the two measurements was generally low for all six markers. TNF-α was significantly higher in spontaneous sputum at exacerbations (p = 0.002) and trending higher at the steady state (p = 0.06). Correlation coefficients between the levels of markers in induced and spontaneous sputum varied between 0.58 (IL-18) to 0.83 (IP-10). In spontaneous sputum IL-18 and MIG were higher in ex-smokers (p < 0.05). The levels of all markers were higher in GOLD stage III & IV except for IL-6 in spontaneous sputum and IL-18 in induced sputum, compared with GOLD stage II, although not statistically significant. In spontaneous sputum the levels of IL-6 were significantly higher if Haemophilus influenzae (HI) was not cultured.

Conclusion

We observed a low agreement and significant differences in inflammatory markers between induced and spontaneous sputum, both at steady state and exacerbations. We recommend considering sampling method when reporting on inflammatory markers in sputum.
Appendix
Available only for authorised users
Literature
2.
go back to reference Brusasco V, Crimi E, Pellegrino R: Airway inflammation in COPD: friend or foe?. Am J Respir Crit Care Med. 2007, 176: 425-426. 10.1164/rccm.200706-820ED.PubMedCrossRef Brusasco V, Crimi E, Pellegrino R: Airway inflammation in COPD: friend or foe?. Am J Respir Crit Care Med. 2007, 176: 425-426. 10.1164/rccm.200706-820ED.PubMedCrossRef
3.
go back to reference Warwick G, Thomas PS, Yates DH: Non-invasive biomarkers in exacerbations of obstructive lung disease. Respirology. 2013, 18: 874-884. 10.1111/resp.12089.PubMedCrossRef Warwick G, Thomas PS, Yates DH: Non-invasive biomarkers in exacerbations of obstructive lung disease. Respirology. 2013, 18: 874-884. 10.1111/resp.12089.PubMedCrossRef
4.
go back to reference Paggiaro PL, Chanez P, Holz O, Ind PW, Djukanovic R, Maestrelli P, Sterk PJ: Sputum induction. Eur Respir J Suppl. 2002, 37: 3s-8s.PubMed Paggiaro PL, Chanez P, Holz O, Ind PW, Djukanovic R, Maestrelli P, Sterk PJ: Sputum induction. Eur Respir J Suppl. 2002, 37: 3s-8s.PubMed
5.
go back to reference Dragonieri S, Tongoussouva O, Zanini A, Imperatori A, Spanevello A: Markers of airway inflammation in pulmonary diseases assessed by induced sputum. Monaldi Arch Chest Dis. 2009, 71: 119-126.PubMed Dragonieri S, Tongoussouva O, Zanini A, Imperatori A, Spanevello A: Markers of airway inflammation in pulmonary diseases assessed by induced sputum. Monaldi Arch Chest Dis. 2009, 71: 119-126.PubMed
6.
go back to reference Wark PA, Simpson JL, Hensley MJ, Gibson PG: Safety of sputum induction with isotonic saline in adults with acute severe asthma. Clin Exp Allergy. 2001, 31: 1745-1753. 10.1046/j.1365-2222.2001.01230.x.PubMedCrossRef Wark PA, Simpson JL, Hensley MJ, Gibson PG: Safety of sputum induction with isotonic saline in adults with acute severe asthma. Clin Exp Allergy. 2001, 31: 1745-1753. 10.1046/j.1365-2222.2001.01230.x.PubMedCrossRef
7.
go back to reference Gao P, Gibson PG, Zhang J, He X, Hao Y, Li P, Liu H: The safety of sputum induction in adults with acute exacerbation of COPD. Clin Respir J. 2013, 7: 101-109. 10.1111/j.1752-699X.2012.00291.x.PubMedCrossRef Gao P, Gibson PG, Zhang J, He X, Hao Y, Li P, Liu H: The safety of sputum induction in adults with acute exacerbation of COPD. Clin Respir J. 2013, 7: 101-109. 10.1111/j.1752-699X.2012.00291.x.PubMedCrossRef
8.
go back to reference Tsoumakidou M, Tzanakis N, Siafakas NM: Induced sputum in the investigation of airway inflammation of COPD. Respir Med. 2003, 97: 863-871. 10.1016/S0954-6111(03)00035-0.PubMedCrossRef Tsoumakidou M, Tzanakis N, Siafakas NM: Induced sputum in the investigation of airway inflammation of COPD. Respir Med. 2003, 97: 863-871. 10.1016/S0954-6111(03)00035-0.PubMedCrossRef
9.
go back to reference Makris D, Tzanakis N, Moschandreas J, Siafakas NM: Dyspnea assessment and adverse events during sputum induction in COPD. BMC Pulm Med. 2006, 6: 17-10.1186/1471-2466-6-17.PubMedPubMedCentralCrossRef Makris D, Tzanakis N, Moschandreas J, Siafakas NM: Dyspnea assessment and adverse events during sputum induction in COPD. BMC Pulm Med. 2006, 6: 17-10.1186/1471-2466-6-17.PubMedPubMedCentralCrossRef
10.
go back to reference Taube C, Holz O, Mucke M, Jorres RA, Magnussen H: Airway response to inhaled hypertonic saline in patients with moderate to severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001, 164: 1810-1815. 10.1164/ajrccm.164.10.2104024.PubMedCrossRef Taube C, Holz O, Mucke M, Jorres RA, Magnussen H: Airway response to inhaled hypertonic saline in patients with moderate to severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001, 164: 1810-1815. 10.1164/ajrccm.164.10.2104024.PubMedCrossRef
11.
go back to reference Bathoorn E, Liesker J, Postma D, Koeter G, van Oosterhout AJ, Kerstjens HA: Safety of sputum induction during exacerbations of COPD. Chest. 2007, 131: 432-438. 10.1378/chest.06-2216.PubMedCrossRef Bathoorn E, Liesker J, Postma D, Koeter G, van Oosterhout AJ, Kerstjens HA: Safety of sputum induction during exacerbations of COPD. Chest. 2007, 131: 432-438. 10.1378/chest.06-2216.PubMedCrossRef
12.
go back to reference Bafadhel M, McCormick M, Saha S, McKenna S, Shelley M, Hargadon B, Mistry V, Reid C, Parker D, Dodson P, Jenkins M, Lloyd A, Rugman P, Newbold P, Brightling CE: Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease. Respiration. 2012, 83: 36-44. 10.1159/000330667.PubMedPubMedCentralCrossRef Bafadhel M, McCormick M, Saha S, McKenna S, Shelley M, Hargadon B, Mistry V, Reid C, Parker D, Dodson P, Jenkins M, Lloyd A, Rugman P, Newbold P, Brightling CE: Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease. Respiration. 2012, 83: 36-44. 10.1159/000330667.PubMedPubMedCentralCrossRef
13.
go back to reference Wallace J, D’Silva L, Brannan J, Hargreave FE, Kanaroglou P, Nair P: Association between proximity to major roads and sputum cell counts. Can Respir J. 2011, 18: 13-18.PubMedPubMedCentral Wallace J, D’Silva L, Brannan J, Hargreave FE, Kanaroglou P, Nair P: Association between proximity to major roads and sputum cell counts. Can Respir J. 2011, 18: 13-18.PubMedPubMedCentral
14.
go back to reference Ronchi MC, Piragino C, Rosi E, Amendola M, Duranti R, Scano G: Role of sputum differential cell count in detecting airway inflammation in patients with chronic bronchial asthma or COPD. Thorax. 1996, 51: 1000-1004. 10.1136/thx.51.10.1000.PubMedPubMedCentralCrossRef Ronchi MC, Piragino C, Rosi E, Amendola M, Duranti R, Scano G: Role of sputum differential cell count in detecting airway inflammation in patients with chronic bronchial asthma or COPD. Thorax. 1996, 51: 1000-1004. 10.1136/thx.51.10.1000.PubMedPubMedCentralCrossRef
15.
go back to reference Pizzichini MM, Popov TA, Efthimiadis A, Hussack P, Evans S, Pizzichini E, Dolovich J, Hargreave FE: Spontaneous and induced sputum to measure indices of airway inflammation in asthma. Am J Respir Crit Care Med. 1996, 154: 866-869. 10.1164/ajrccm.154.4.8887576.PubMedCrossRef Pizzichini MM, Popov TA, Efthimiadis A, Hussack P, Evans S, Pizzichini E, Dolovich J, Hargreave FE: Spontaneous and induced sputum to measure indices of airway inflammation in asthma. Am J Respir Crit Care Med. 1996, 154: 866-869. 10.1164/ajrccm.154.4.8887576.PubMedCrossRef
16.
go back to reference Bhowmik A, Seemungal TA, Sapsford RJ, Devalia JL, Wedzicha JA: Comparison of spontaneous and induced sputum for investigation of airway inflammation in chronic obstructive pulmonary disease. Thorax. 1998, 53: 953-956. 10.1136/thx.53.11.953.PubMedPubMedCentralCrossRef Bhowmik A, Seemungal TA, Sapsford RJ, Devalia JL, Wedzicha JA: Comparison of spontaneous and induced sputum for investigation of airway inflammation in chronic obstructive pulmonary disease. Thorax. 1998, 53: 953-956. 10.1136/thx.53.11.953.PubMedPubMedCentralCrossRef
17.
go back to reference Koutsokera A, Kostikas K, Nicod LP, Fitting JW: Pulmonary biomarkers in COPD exacerbations: a systematic review. Respir Res. 2013, 14: 111-10.1186/1465-9921-14-111.PubMedPubMedCentralCrossRef Koutsokera A, Kostikas K, Nicod LP, Fitting JW: Pulmonary biomarkers in COPD exacerbations: a systematic review. Respir Res. 2013, 14: 111-10.1186/1465-9921-14-111.PubMedPubMedCentralCrossRef
18.
go back to reference Eagan TM, Ueland T, Wagner PD, Hardie JA, Mollnes TE, Damas JK, Aukrust P, Bakke PS: Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study. Eur Respir J. 2010, 35: 540-548. 10.1183/09031936.00088209.PubMedCrossRef Eagan TM, Ueland T, Wagner PD, Hardie JA, Mollnes TE, Damas JK, Aukrust P, Bakke PS: Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study. Eur Respir J. 2010, 35: 540-548. 10.1183/09031936.00088209.PubMedCrossRef
19.
go back to reference Seemungal TA, Donaldson GC, Bhowmik A, Jeffries DJ, Wedzicha JA: Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000, 161: 1608-1613. 10.1164/ajrccm.161.5.9908022.PubMedCrossRef Seemungal TA, Donaldson GC, Bhowmik A, Jeffries DJ, Wedzicha JA: Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000, 161: 1608-1613. 10.1164/ajrccm.161.5.9908022.PubMedCrossRef
20.
go back to reference Efthimiadis A, Spanevello A, Hamid Q, Kelly MM, Linden M, Louis R, Pizzichini MM, Pizzichini E, Ronchi C, Van Overvel F, Djukanovic R: Methods of sputum processing for cell counts, immunocytochemistry and in situ hybridisation. Eur Respir J Suppl. 2002, 37: 19s-23s.PubMed Efthimiadis A, Spanevello A, Hamid Q, Kelly MM, Linden M, Louis R, Pizzichini MM, Pizzichini E, Ronchi C, Van Overvel F, Djukanovic R: Methods of sputum processing for cell counts, immunocytochemistry and in situ hybridisation. Eur Respir J Suppl. 2002, 37: 19s-23s.PubMed
21.
go back to reference Bland JM, Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986, 1: 307-310. 10.1016/S0140-6736(86)90837-8.PubMedCrossRef Bland JM, Altman DG: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986, 1: 307-310. 10.1016/S0140-6736(86)90837-8.PubMedCrossRef
22.
go back to reference Bland JM, Altman DG: Measuring agreement in method comparison studies. Stat Methods Med Res. 1999, 8: 135-160. 10.1191/096228099673819272.PubMedCrossRef Bland JM, Altman DG: Measuring agreement in method comparison studies. Stat Methods Med Res. 1999, 8: 135-160. 10.1191/096228099673819272.PubMedCrossRef
23.
go back to reference Woolhouse IS, Bayley DL, Stockley RA: Effect of sputum processing with dithiothreitol on the detection of inflammatory mediators in chronic bronchitis and bronchiectasis. Thorax. 2002, 57: 667-671. 10.1136/thorax.57.8.667.PubMedPubMedCentralCrossRef Woolhouse IS, Bayley DL, Stockley RA: Effect of sputum processing with dithiothreitol on the detection of inflammatory mediators in chronic bronchitis and bronchiectasis. Thorax. 2002, 57: 667-671. 10.1136/thorax.57.8.667.PubMedPubMedCentralCrossRef
24.
go back to reference Holz O, Jorres RA, Koschyk S, Speckin P, Welker L, Magnussen H: Changes in sputum composition during sputum induction in healthy and asthmatic subjects. Clin Exp Allergy. 1998, 28: 284-292. 10.1046/j.1365-2222.1998.00243.x.PubMedCrossRef Holz O, Jorres RA, Koschyk S, Speckin P, Welker L, Magnussen H: Changes in sputum composition during sputum induction in healthy and asthmatic subjects. Clin Exp Allergy. 1998, 28: 284-292. 10.1046/j.1365-2222.1998.00243.x.PubMedCrossRef
25.
go back to reference Gershman NH, Liu H, Wong HH, Liu JT, Fahy JV: Fractional analysis of sequential induced sputum samples during sputum induction: evidence that different lung compartments are sampled at different time points. J Allergy Clin Immunol. 1999, 104: 322-328. 10.1016/S0091-6749(99)70374-X.PubMedCrossRef Gershman NH, Liu H, Wong HH, Liu JT, Fahy JV: Fractional analysis of sequential induced sputum samples during sputum induction: evidence that different lung compartments are sampled at different time points. J Allergy Clin Immunol. 1999, 104: 322-328. 10.1016/S0091-6749(99)70374-X.PubMedCrossRef
27.
go back to reference Moodley YP, Krishnan V, Lalloo UG: Neutrophils in induced sputum arise from central airways. Eur Respir J. 2000, 15: 36-40. 10.1183/09031936.00.15103600.PubMedCrossRef Moodley YP, Krishnan V, Lalloo UG: Neutrophils in induced sputum arise from central airways. Eur Respir J. 2000, 15: 36-40. 10.1183/09031936.00.15103600.PubMedCrossRef
28.
29.
go back to reference Erb-Downward JR, Thompson DL, Han MK, Freeman CM, McCloskey L, Schmidt LA, Young VB, Toews GB, Curtis JL, Sundaram B, Martinez FJ, Huffnagle GB: Analysis of the lung microbiome in the “healthy” smoker and in COPD. PLoS One. 2011, 6: e16384-10.1371/journal.pone.0016384.PubMedPubMedCentralCrossRef Erb-Downward JR, Thompson DL, Han MK, Freeman CM, McCloskey L, Schmidt LA, Young VB, Toews GB, Curtis JL, Sundaram B, Martinez FJ, Huffnagle GB: Analysis of the lung microbiome in the “healthy” smoker and in COPD. PLoS One. 2011, 6: e16384-10.1371/journal.pone.0016384.PubMedPubMedCentralCrossRef
30.
go back to reference Perera WR, Hurst JR, Wilkinson TM, Sapsford RJ, Mullerova H, Donaldson GC, Wedzicha JA: Inflammatory changes, recovery and recurrence at COPD exacerbation. Eur Respir J. 2007, 29: 527-534. 10.1183/09031936.00092506.PubMedCrossRef Perera WR, Hurst JR, Wilkinson TM, Sapsford RJ, Mullerova H, Donaldson GC, Wedzicha JA: Inflammatory changes, recovery and recurrence at COPD exacerbation. Eur Respir J. 2007, 29: 527-534. 10.1183/09031936.00092506.PubMedCrossRef
31.
go back to reference Kersul AL, Iglesias A, Rios A, Noguera A, Forteza A, Serra E, Agusti A, Cosio BG: Molecular mechanisms of inflammation during exacerbations of chronic obstructive pulmonary disease. Arch Bronconeumol. 2011, 47: 176-183. 10.1016/j.arbres.2010.12.003.PubMedCrossRef Kersul AL, Iglesias A, Rios A, Noguera A, Forteza A, Serra E, Agusti A, Cosio BG: Molecular mechanisms of inflammation during exacerbations of chronic obstructive pulmonary disease. Arch Bronconeumol. 2011, 47: 176-183. 10.1016/j.arbres.2010.12.003.PubMedCrossRef
32.
go back to reference Pizzichini E, Pizzichini MM, Leigh R, Djukanovic R, Sterk PJ: Safety of sputum induction. Eur Respir J Suppl. 2002, 37: 9s-18s.PubMed Pizzichini E, Pizzichini MM, Leigh R, Djukanovic R, Sterk PJ: Safety of sputum induction. Eur Respir J Suppl. 2002, 37: 9s-18s.PubMed
Metadata
Title
Comparison of inflammatory markers in induced and spontaneous sputum in a cohort of COPD patients
Authors
Solveig Tangedal
Marianne Aanerud
Louise JP Persson
Karl A Brokstad
Per S Bakke
Tomas M Eagan
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2014
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/s12931-014-0138-6

Other articles of this Issue 1/2014

Respiratory Research 1/2014 Go to the issue